Core Viewpoint - Thermo Fisher Scientific is considering selling part of its diagnostics business due to industry concerns over federal spending cuts on research, with a target sale price of around $4 billion [1][2]. Company Summary - The diagnostics unit of Thermo Fisher produces infectious disease testing equipment and is currently under evaluation for potential sale to private equity firms [2][3]. - The company has experienced a 20% decline in its shares this year, while competitors Danaher and Becton, Dickinson and Company have seen declines of 11% and 23%, respectively [4]. - In the first quarter, Thermo Fisher reported a year-over-year organic revenue growth of 1% [4]. - The CEO of Thermo Fisher expressed pride in the company's strong performance amid a challenging macroeconomic environment [5]. Industry Summary - The healthcare sector is facing volatility due to concerns about the impact of federal budget cuts on research funding, particularly cuts proposed by President Donald Trump to the National Institutes of Health [3]. - Becton, Dickinson and Company announced plans to separate its life sciences business, which includes a diagnostics segment, to enhance focus and value [6][7].

COMBINED GENERAL MEETING ON 13 JUNE 2025_____ Dividend of €0.76 per share, to be paid out on 20 June 2025 Paris, 13 June 2025 (6:30pm) - ADLPartner’s Combined General Meeting, chaired by Mr Bertrand Laurioz, Chairman of the Board of Directors, was held today. Approval of the full-year accounts for 2024 The general meeting approved the corporate and consolidated financial statements for the year ended 31 December 2024. Dividend pay-out In line with the Board of Directors proposal, the general meeting decide ...

Follow your dreams. That saying is heard everywhere. But what is a dream.Is it the dream I had last night about diving into ice cream. Well, that is a dream, just not the kind of dream I'm talking about today. These dreams are the visions that one has for their own future that they want to see come to fruition.These can mean career dreams. So, just wanting to become a firefighter or a lawyer. My dream is to become a medical doctor so that I can live a life of helping others and make a difference in the worl ...

Key Takeaways TGT raised its quarterly dividend by 1.8% to $1.14 per share, payable on Sept. 1, 2025. TGT's buybacks continue, with $251M spent in Q1 and $8.4B left under its current repurchase plan. Despite efficiency gains, weak traffic and pressured categories may slow Target's recovery in 2025.Target Corporation (TGT) has once again demonstrated its commitment to rewarding its shareholders by announcing a 1.8% increase in its quarterly dividend. The retail giant raised its dividend from $1.12 to $1.14 ...

Core Viewpoint - Lovesac is emerging from legal issues and is positioned for a potential rebound in share price driven by growth, operational quality, and a shift towards sustainable profitability, despite existing risks [1][2]. Financial Performance - Lovesac reported Q1 net revenue of $138.4 million, reflecting a growth rate of 4.4%, outperforming competitors like Ethan Allen and La-Z-Boy, which are growing at slower rates or experiencing declines [4]. - The company has increased its store count by 21 compared to the previous year, with sales in that channel up by 18%. However, digital and other categories saw declines of 9% and 40.5%, respectively [5]. - Operational quality improvements led to a contraction in gross margin by 60 basis points and a reduction in SG&A expenses by 310 basis points, resulting in a significant contraction of GAAP losses by over 1,600 basis points [5][6]. Guidance and Analyst Outlook - Management has increased guidance for the year, expecting revenue around $725 million and EPS of approximately $1.05, both exceeding consensus forecasts [6]. - Analysts maintain a bullish outlook on Lovesac, with a consistent "Buy" rating and a price target of $31.67, indicating a potential upside of 88.27% from the current price of $16.82 [7][9]. Share Buyback and Risks - Lovesac initiated a share buyback program, significantly reducing share count, but faces risks of ceasing or reversing this program due to decreased cash position and assets [8][9]. - The expected average share count is projected to increase by 11.6% between Q2 and the full year, which may offset the impact of buybacks [10]. - Short interest remains elevated at over 20%, posing a risk of further stock price decline if shorts re-enter the market [11].

The S&P 500 has authorized record stock buybacks so far this year in what could be a lifeline for the stock market in turbulent times. https://t.co/LIMrBCuRCV ...

Valuation Metrics - GF Value is used for valuation, including price to GF Value, which is essential for back testing [1] - Back testing can be performed by ranking based on price to GF Value [1] Back Testing Analysis - Back testing functionality is supported, allowing users to add parameters [2][3] - Limiting the back testing to SP500 companies yields more sensible results [2] - A random GF Value back testing over the last three years (from 2022 to current) shows potential market outperformance [2]

GAZTRANSPORT ET TECHNIGAZSociété anonyme with a share capital of €371,177.72Registered office: 1 route de Versailles – 78470 Saint-Rémy-lès-Chevreuse, France662 001 403 R.C.S. Versailles Main terms and conditions of the share buy-back programme in accordance with the conditions and obligations set by Articles 241-1 and seq. of the General Regulations of the Autorité des marchés financiers (AMF) Implementation of the share buy-back programme authorised by the Combined Shareholders’ meeting on June 11, 2025 I ...

Key Takeaways EWBC expects 2025 NII growth at or above the top end of the prior stated 4-6%. Revenue growth for 2025 is projected to exceed 6%, up from the earlier mentioned 5-7%. EWBC's clients have mitigated tariff risks through supply-chain diversification and relocation.East West Bancorp, Inc. (EWBC) provided insight into its strategic growth amid the ongoing uncertainty at the Morgan Stanley US Financials Conference. The company’s CFO, Chris DelMoral Niles, revised its net interest income (NII) and r ...

Core Insights - Applied Industrial Technologies, Inc. (AIT) is positioned for growth with strong performance in key markets such as technology, food & beverage, pulp & paper, aggregates, and transportation [1] - The Engineered Solutions segment saw a revenue increase of 13.5% year over year in Q3 FY25, driven by technology-related fluid power demand [1][7] Acquisitions and Market Expansion - AIT is focused on enhancing its capabilities through acquisitions, which positively impacted sales by 6.6% in the fiscal third quarter [2] - Recent acquisitions include IRIS Factory Automation and Hydradyne, which have strengthened AIT's automation and fluid power offerings, respectively [2] - The acquisition of Grupo Kopar in May 2024 expanded AIT's automation platform into Mexico [2] Shareholder Returns - AIT has committed to rewarding shareholders with dividends and share buybacks, paying out $46.2 million in dividends in the first nine months of fiscal 2025, an increase of 11.2% year over year [3] - A quarterly dividend rate hike of 24% was implemented in January 2025 [3] - A new share buyback program was authorized in April 2025 to repurchase up to 1.5 million shares [4] Financial Performance - AIT's stock has gained 20.9% over the past year, outperforming the industry growth of 4.2% [5] - The Service Center revenues fell by 3.5% in Q3 FY25 due to weak MRO and local account sales [7][8] - SG&A expenses increased by 4.1% year over year in Q3 FY25, reaching 19.4% of total revenues [9]